VivoSim Labs, Inc. (VIVS)
0.281
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:37
VivoSim Labs Total Assets (Quarterly) : 3.847M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.847M |
| March 31, 2026 | 7.503M |
| December 31, 2025 | 6.96M |
| September 30, 2025 | 9.686M |
| June 30, 2025 | 11.98M |
| March 31, 2025 | 14.65M |
| December 31, 2024 | 3.844M |
| September 30, 2024 | 6.754M |
| June 30, 2024 | 9.47M |
| March 31, 2024 | 6.349M |
| December 31, 2023 | 8.881M |
| September 30, 2023 | 11.16M |
| June 30, 2023 | 14.76M |
| March 31, 2023 | 20.31M |
| December 31, 2022 | 25.08M |
| September 30, 2022 | 27.91M |
| June 30, 2022 | 30.55M |
| March 31, 2022 | 33.30M |
| December 31, 2021 | 35.10M |
| September 30, 2021 | 35.88M |
| June 30, 2021 | 38.29M |
| March 31, 2021 | 39.92M |
| December 31, 2020 | 21.58M |
| September 30, 2020 | 20.64M |
| June 30, 2020 | 25.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.44M |
| December 31, 2019 | 31.31M |
| September 30, 2019 | 37.77M |
| June 30, 2019 | 43.45M |
| March 31, 2019 | 40.62M |
| December 31, 2018 | 39.68M |
| September 30, 2018 | 42.62M |
| June 30, 2018 | 45.09M |
| March 31, 2018 | 49.83M |
| December 31, 2017 | 53.55M |
| September 30, 2017 | 56.91M |
| June 30, 2017 | 61.71M |
| March 31, 2017 | 69.18M |
| December 31, 2016 | 76.13M |
| September 30, 2016 | 57.54M |
| June 30, 2016 | 58.85M |
| March 31, 2016 | 67.58M |
| December 31, 2015 | 74.54M |
| September 30, 2015 | 81.68M |
| June 30, 2015 | 90.56M |
| March 31, 2015 | 53.49M |
| December 31, 2014 | 52.07M |
| September 30, 2014 | 56.54M |
| June 30, 2014 | 46.91M |
| March 31, 2014 | 50.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.193M |
| Shareholders Equity (Quarterly) | -2.346M |
| Debt to Equity Ratio | -0.1347 |
| Current Ratio | 1.704 |
| Net Debt Paydown Yield | 4.41% |